Journal Watch - Peritoneal Dialysis
SARS-CoV-2 in PD Effluent
Analysis of bodily fluids from 3 SARS-CoV-2-infected PD patients found that, while viral load was quite high in nasopharyngeal swabs, none of the PD effluent tested positive, even after dialysate concentration. This suggests that the risk of virus transmission from used PD fluid may be low.
Read the abstract » | (added 2020-09-11)
Tags: COVID 19, SARS CoV 2, Peritoneal Dialysis
International Use of PD
Worldwide PD use is approximately 11%, which varies across the globe, finds a new survey of stakeholders in 182 countries (with 313 respondents from 160 countries). Median PD use was 38.1 per million. Thirty countries, mainly low-income, did not offer PD, while in 69% of countries, PD was the first modality for <10% of incident patients. The range of PD costs passed on to patients was 1-25%, with higher co-pays in South Asia and low-income countries. Patient-reported PD outcomes were rarely measured.
Read the abstract » | (added 2020-09-11)
Starting with PD Better than Switching to it from HD
A metaanalysis comparing patients who started with PD to those who began HD and then switched to PD after 3 months found significantly better overall and technique survival in the PD first group. There were no significant differences in the peritonitis rate.
Read the abstract » | (added 2020-07-10)
Tags: Hemodialysis, Peritoneal Dialysis, Renal Replacement Therapy
Are PD eHealth Initiatives Ready for Prime Time?
A review of 15 studies (n=1,334) of use of telemedicine and eHealth to support PD self-management found bias and low-quality evidence that made a metaanalysis impossible. While no adverse effects of eHealth interventions were reported, effectiveness was mixed. Better quality evidence is needed.
Read the abstract » | (added 2020-05-12)
Tags: Digital Health, EHealth, Peritoneal Dialysis, Evidence
Outcomes Between Urgent-start PD and HD
Urgent-start PD (n=93) and urgent-start HD (n=91) patients similar in age, diabetes and other comorbidities, and lab values, were followed for 6 months to 2 years. Rates of mechanical complications, bacteremia, and survival were comparable. Exit site/access infections were significantly higher in the PD patients, but those on PD had significantly better residual kidney function and phosphorus control, and used significantly less erythropoietin and antihypertensives
Read the abstract » | (added 2020-04-13)
Tags: Haemodialysis, Renal Function Recovery, Peritoneal Dialysis, Urgent Start